ARTICLE | Distillery Therapeutics
Therapeutics: Galactosylceramidase (GALC)
April 30, 2015 7:00 AM UTC
Mouse studies suggest combining GALC gene therapy, the sphingolipid synthesis inhibitor L-cycloserine and bone marrow transplantation could help treat globoid cell leukodystrophy (Krabbe disease). Kra...